Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07054398Recruiting
Catestatin levels in acne patients
This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.
AswānAges 18–40 - NCT07054567RecruitingPhase 2
Study of BL-B01D1 plus Keytruda for advanced cervical or endometrial cancer
This trial tests a new drug combination for people with cervical or endometrial cancer that has come back or spread. The study aims to see if adding BL-B01D1 to Keytruda (with or without Avastin) can help shrink tumors or slow the cancer's growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07054892Recruiting
Ankle sprain: how it affects your daily life
This study checks how an ankle sprain affects your daily life and well-being. If you came to the Saint-Brieuc emergency room with a twisted or sprained ankle (no broken bone or need for surgery), researchers will ask you about your recovery and quality of life over time.
Saint-BrieucAges 18 years+ - NCT07055152Recruiting
Eye scan to understand heart attack risk in MINOCA patients
This study uses a special eye scan (OCTA) to look at tiny blood vessels in the eye and see if they can help predict outcomes for people who had a heart attack without blocked arteries (MINOCA). It compares these patients to others with typical heart attacks and healthy people.
Pisa, PisaAges Any age - NCT07055243RecruitingPhase 2
Mitapivat for red blood cell membrane disorders or CDAII
This trial tests if mitapivat, an experimental pill, can safely improve anemia and reduce symptoms like fatigue in people with inherited red blood cell membrane disorders or congenital dyserythropoietic anemia type II (CDAII). It is a proof-of-concept study to see if the drug works.
Toronto, OntarioAges 18 years+ - NCT07055581RecruitingPhase 2
Durvalumab after initial treatment for limited-stage lung cancer
This trial tests whether the immunotherapy drug durvalumab can help keep limited-stage small cell lung cancer from coming back after standard treatment. You would receive durvalumab as a 'consolidation' (maintenance) therapy.
Zhengzhou, HenanAges 18 years+ - NCT07056192Recruiting
How information affects anxiety during uroflowmetry
This trial studies whether giving verbal or written information before a uroflowmetry test (a simple urine flow test) affects your anxiety and satisfaction. You may join if you are having this test for the first time and can understand Urdu or English.
Karachi, SindhAges 18 years+ - NCT07056595Recruiting
Finerenone for IgA nephropathy patients
This trial tests whether finerenone can help people with IgA nephropathy, a kidney disease. It is for adults with high protein in their urine who are already on standard kidney-protecting medications.
MoscowAges 18 years+ - NCT07056556RecruitingPhase 1
Study of BL-M09D1 for advanced lung and other solid tumors
This trial tests a new drug, BL-M09D1, in people with advanced non-small cell lung cancer or other solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07057232Recruiting
Chronic insomnia treatment for non-cancer pain patients
This study is testing a treatment for chronic insomnia (trouble sleeping) in people who have long-term pain from non-cancer causes. Researchers want to see if improving sleep can help you manage your pain better.
Badalona, CataloniaAges 18 years+ - NCT07057375Recruiting
Pulsed magnetic field therapy for muscle loss from hormone treatment
This study tests whether pulsed electromagnetic field therapy can help prevent or reverse muscle loss and weakness caused by hormone therapy (ADT) for prostate cancer. The treatment is non-invasive and may help you stay stronger during your cancer care.
ShatinAges 18 years+ - NCT07057596RecruitingPhase 2
Tebentafusp before surgery for uveal melanoma in the liver
This trial tests a drug called tebentafusp before surgery for uveal melanoma that has spread to the liver. The goal is to see if giving the drug first can shrink the tumors and make surgery more effective.
Berlin, State of BerlinAges 18 years+ - NCT07058207Recruiting
Weight management program for obese cancer patients in treatment
This study offers a weight management program for people with obesity who are undergoing active cancer treatment (chemo or radiation) for a solid tumor. It aims to help you manage your weight while you fight cancer, and requires living in the Barcelona area.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+ - NCT07058454Recruiting
Heart safety study for targeted cancer therapies
This study looks at how targeted cancer treatments affect the heart. If you are an adult with any type of cancer and are getting or will get chemotherapy (including targeted drugs), joining this study helps doctors understand heart risks better.
Guangzhou, GuangdongAges 18 years+ - NCT07058636Recruiting
Nerve block plus trigger point shots for neck pain relief
This study tests if adding a nerve block to standard trigger point injections provides better relief for people with chronic neck pain caused by myofascial pain syndrome.
AnkaraAges 18–65 - NCT07058831Recruiting
Home monitoring for hidden atrial fibrillation in older adults with high blood pressure
This study tests if home monitoring can detect hidden atrial fibrillation in older adults with high blood pressure and certain risk factors. It aims to catch this irregular heartbeat early so treatment can prevent strokes and other complications.
Rosario, Santa Fe ProvinceAges 65 years+ - NCT07058857Recruiting
Ear stimulation test for heart attack recovery
This study tests whether gentle electrical stimulation on the tragus (small bump near your ear opening) can improve heart function in people having a first heart attack. This treatment is non-invasive and could help protect your heart from damage.
Semarang, Central of JavaAges 18–75 - NCT07059026Recruiting
Thrombotic microangiopathy after stem cell transplant in adults
This study looks at people who have a blood clotting problem called TMA after a stem cell transplant from a donor. It gathers information from routine checkups to learn more about this condition.
Buenos AiresAges 18 years+ - NCT07059351Recruiting
Mouth health and pneumonia risk after stroke
This study looks at how oral health affects the chances of developing pneumonia after a stroke and how well people recover their ability to swallow. It may help find ways to prevent complications and improve recovery for stroke survivors with swallowing problems.
GhentAges 18 years+ - NCT07059377RecruitingPhase 3
Semaglutide to help smokers with diabetes quit
This study tests if the diabetes drug semaglutide can help people with type 2 diabetes stop smoking more easily. Participants will get either semaglutide or a placebo to see if it improves quit rates.
Ottawa, OntarioAges 18 years+ - NCT07059650RecruitingPhase 1/Phase 2
DZD8586 combo therapy for diffuse large B-cell lymphoma
This trial tests a new combination treatment (DZD8586) for people with diffuse large B-cell lymphoma (DLBCL). It looks at how well the drug works and how safe it is for both newly diagnosed patients and those whose cancer returned after initial treatment.
BeijingAges 18 years+ - NCT07059663Recruiting
Schroth method with core exercises for scoliosis
This study tests if adding core-strengthening exercises to the Schroth method helps teenagers with idiopathic scoliosis better than the Schroth method alone. It aims to find a more effective way to improve posture and reduce curve progression.
Lahore, Punjab ProvinceAges 10–18 - NCT07059871Recruiting
Silkworm powder for nutrition in Alzheimer's disease
This trial tests whether a dietary supplement made from silkworm pupa powder can improve nutrition in people with Alzheimer's disease. It looks at weight, nutrition risk, and daily living skills over time.
Hangzhou, ZhejiangAges 50–90 - NCT07059936Recruiting
AI and scans to predict immunotherapy response in liver cancer
This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.
Wuhan, HubeiAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.